Literature DB >> 3488762

Characterization of cellular and extracellular plasma membrane vesicles from a low metastatic lymphoma (Eb) and its high metastatic variant (ESb): inhibitory capacity in cell-cell interaction systems.

V Schirrmacher, D Barz.   

Abstract

Spontaneously shed extracellular plasma membrane vesicles (ECM) of a highly metastatic murine tumor line (ESb) were compared with plasma membrane vesicles (PM) of the same cells prepared by the nitrogen cavitation method and with ECM and PM preparations of the related low metastatic tumor line Eb. From a previous biochemical analysis it was concluded that the exfoliation of ECM vesicles, which is very pronounced in metastatic ESb cells, is not a random process. This conclusion is further corroborated by the present functional analysis. Compared to ESb PM, ESb-derived ECM were selectively enriched for Fc receptors and depleted in glycoproteins with affinity for hepatocytes. Tumor-derived ECM carried the same tumor antigen as the corresponding tumor line and showed in comparison to PM material an increased inhibitor capacity in a T-cell-mediated tumor-specific cytotoxicity test.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488762     DOI: 10.1016/0005-2736(86)90519-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy.

Authors:  Bashdar Mahmud Hussen; Goran Sedeeq Hama Faraj; Mohammad Fatih Rasul; Hazha Jamal Hidayat; Abbas Salihi; Aria Baniahmad; Mohammad Taheri; Soudeh Ghafouri-Frad
Journal:  Cancer Cell Int       Date:  2022-10-18       Impact factor: 6.429

2.  Oncogene expression in related cancer lines differing in metastatic capacity.

Authors:  J Pohl; A Radler-Pohl; R Heicappell; V Schirrmacher
Journal:  Clin Exp Metastasis       Date:  1988 May-Jun       Impact factor: 5.150

3.  Comparative study on Lewis lung tumour lines with 'low' and 'high' metastatic capacity. III. Glycosaminoglycan synthesis, transport and degradation in cell lines.

Authors:  G Pogány; E Moczar; A Jeney; J Timár; F Timár; K Ditrói; K Lapis
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

4.  Determination of cell-free interleukin 2 receptor level in the serum of normal animals and of animals bearing IL-2 receptor positive tumours with high or low metastatic capacity.

Authors:  V Schirrmacher; O Josimovic-Alasevic; H Osawa; T Diamantstein
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

Review 5.  Tumour Derived Extracellular Vesicles: Challenging Target to Blunt Tumour Immune Evasion.

Authors:  Tatiana Lopatina; Alessandro Sarcinella; Maria Felice Brizzi
Journal:  Cancers (Basel)       Date:  2022-08-20       Impact factor: 6.575

6.  Tumor and endothelial cell-derived microvesicles carry distinct CEACAMs and influence T-cell behavior.

Authors:  Harrison T Muturi; Janine D Dreesen; Elena Nilewski; Holger Jastrow; Bernd Giebel; Suleyman Ergun; Bernhard B Singer
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

Review 7.  Exosome-Based Vaccines: History, Current State, and Clinical Trials.

Authors:  Patrick Santos; Fausto Almeida
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.